Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you're searching for how to reconstitute 5mg semaglutide, the most important fact to reach first is this: licensed semaglutide weight-loss medicines available in the UK — Wegovy injection and the new Wegovy tablet — are supplied ready to use and do not require reconstitution by the patient. There is no mixing step. The question is understandable, and it matters that you have an accurate answer before doing anything with a product. Wegovy comes as a pre-filled pen with the dose already in solution; reconstitution is a process associated with compounded or research-grade peptides that are not licensed UK weight-loss medicines. If a product you have been given requires mixing, that is a serious signal worth pausing on, and something a prescriber should know about immediately.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A large number of people searching for reconstitution instructions for 5mg semaglutide have encountered a product (usually a small vial of white or off-white powder, sometimes sold with a separate bacteriostatic water ampoule) and assumed it is a legitimate lower-cost version of the medicine they have read about. That assumption is worth gently setting aside.
Semaglutide, when supplied as a licensed weight-loss medicine under the brand name Wegovy, arrives in a pre-filled injection pen. The solution is already there. You dial the pen, attach a needle, and inject. Nothing is weighed, measured, dissolved or drawn up. The titration schedule (starting at 0.25mg and increasing through 0.5mg, 1mg, 1.7mg and 2.4mg, or up to 7.2mg with the newer pen) is built into the pen design, not left for the patient to calculate. The NHS semaglutide medicines page describes the Wegovy pen straightforwardly as a pre-filled device used once a week.
Vials requiring reconstitution are not part of the licensed Wegovy supply chain. They circulate through unregulated routes, sometimes misrepresented as pharmaceutical-grade, sometimes sold at prices that look appealingly low. The gap between that product and a licensed pen is not a technicality; it is a question of whether the dose you receive is what the label claims, whether it is sterile, and whether anyone clinically qualified has assessed whether you should be taking it at all.
Reconstitution means dissolving a lyophilised (freeze-dried) peptide powder in a sterile liquid, usually bacteriostatic water, to produce an injectable solution. In a pharmaceutical manufacturing facility this process happens under tightly controlled conditions: verified source material, precise concentrations, sterility testing, sealed packaging. When someone at home reconstitutes a peptide vial purchased online, none of those controls exist.
The risks are practical and serious. Incorrect volumes produce incorrect doses, a small error with a concentrated peptide translates into a large swing in how much reaches your system. Contamination during mixing can introduce bacteria directly into an injectable preparation. And without verified analytical testing, there is no way to confirm that the vial contains semaglutide at all, let alone at the stated concentration. The MHRA has warned publicly that fake weight-loss pens and vials have been found to contain insulin, among other substances, leading to hospitalisations. You can report a suspect product or seller at the MHRA's Yellow Card scheme.
None of this is to say that everyone searching for these instructions has bad intentions. Many people have been sold something by someone they trusted. The information here is meant to be useful, not judgmental. If you are holding a vial and water and are unsure what to do, the right next step is a conversation with a clinician, not a YouTube tutorial.
If you are exploring semaglutide for weight management in the UK, the Wegovy dose schedule is set by your prescriber and follows a fixed titration path built around tolerability. The starting point is 0.25mg weekly, not to produce weight loss at that stage, but to let your body adjust before the dose climbs. Each step up is separated by roughly four weeks and only happens when clinically appropriate. The maintenance dose for most people on the standard injection is 2.4mg; from January 2026 a 7.2mg option became available for eligible patients.
The pen itself handles the dosing mechanism. You do not draw up a volume or calculate a concentration. You select the dose on the dial, press the button, and the pen delivers it. Injection sites rotate between the abdomen, thigh and upper arm. Storage is in a refrigerator until the pen is opened, after which the patient information leaflet specifies the window for room-temperature use, always defer to that leaflet rather than any figure quoted online, as the window differs between products.
For anyone who wants to understand how the higher 10mg vial format differs from the injection pen approach, this page on 10mg semaglutide reconstitution covers that context in similar detail. And if you are weighing up how to access licensed treatment, information on where to obtain Wegovy in the UK sets out the regulated routes. Our free consultation page is the starting point for anyone who wants a prescriber's view on whether Wegovy is appropriate for them, a real clinician reads every submission, the same day it arrives.
If you have already purchased something that needs reconstituting and are now reading this, the most useful thing to do is stop and speak to someone qualified before injecting anything. That might be your GP, a pharmacist, or a prescriber at a regulated online clinic. Bring the product packaging, the seller's details, and any documentation you received. If you have a 5mg powder vial and want to understand exactly what the mixing process entails, our detailed guide to 5mg semaglutide reconstitution explains the steps, the risks involved, and what a clinician would want you to consider before proceeding.
Our clinical team at nume includes GPhC-registered Independent Prescribers who review weight-loss treatment questions regularly. They are familiar with the landscape of products people encounter and can give you a clear, honest assessment. There is no obligation to proceed with treatment through us, the conversation itself is what matters here. If you have questions in the meantime, our support team is available seven days a week.
Semaglutide used for weight management is a prescription-only medicine in the UK. The licensed version requires clinical assessment before a prescriber issues it, and that assessment exists precisely because the medicine has real effects, both the intended ones and the ones that need monitoring. Getting the genuine article through a regulated route is not a bureaucratic inconvenience. It is the mechanism by which dosing, safety and follow-up are actually managed. Patients considering the Viogen semaglutide 10mg pen will find that it, like all licensed formats, sits within this same framework of clinical oversight and regulated supply. You can verify any online pharmacy's registration on the GPhC pharmacy register before sharing any personal or health information with them.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.